The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

The Food and Drug Administration has paused distribution of the gene therapy Elevidys following the death of a third patient receiving treatment for muscular dystrophy. Alison and William Small are ...

After a tumultuous year, experts call for stability while anticipating the first fruits of policies intended to expedite ...

Pharmaceutical patent protection can be extended when drug companies bring newer products to market before their first patent ...

On July 23, 2025, the U.S. Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) announced a joint Request for Information (RFI) to gather information and data to help establish ...

(The Center Square) – Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner, Marty Makary, accountable for leaving its promise to review the “dangerous” abortion drug ...

Attorneys general of New York, California, New Jersey and Massachusetts are asking the Food and Drug Administration (FDA) to expand access to the abortion pill and remove some “unnecessary” drug ...